China's 28nm DUV Breakthrough Won't Topple ASML-But It May Start Fracturing ASML's China Revenue

Why the headline matters more as a sentiment shock than an immediate earnings blow

China has begun mass-producing homegrown immersion DUV lithography machines, with Shanghai Aishengna leading the effort. Reuters says the rollout is still early, at about five machines this year, with roughly 20 planned for 2027. Even then, the tools remain far from matching ASML's competing models, and analysts told CNBC performance versus ASML and China's ability to scale production are still unresolved.

That distinction matters. This is less an immediate ASML collapse than a warning that investors may start valuing ASML's China revenue more cautiously.

China's path to substitution starts with "good enough," not global leadership

The first milestone is qualification inside China

China does not need to build a global lithography champion right away. It needs tools that Chinese fabs can qualify, learn on, and treat as a credible backup. The latest domestic immersion DUV effort is reportedly comparable to ASML's 2008-era tools, targets roughly 28nm production, and is aiming for about five machines in 2026 and about 20 in 2027. That is still weak compared with ASML, and Reuters says the machines require further testing. But even a modest domestic option changes the story from monopoly to fallback.

Production data, not headlines, is the real compounding factor

Once the tools move into real factory use, the risk for ASML shifts from today's revenue base to tomorrow's substitution path. Chinese fabs can gather production data, improve local tooling, train operators, and validate service workflows. The machines are expected to be delivered to SMIC, CXMT, and Hua Hong later this year, and Reuters says a domestic system has been tested by SMIC since September 2025. Export controls make that pathway more attractive: Washington has progressively tightened controls, and Reuters says the local tools could become a fallback if foreign servicing tightens.

That feedback loop is the real watchpoint. Every extra tool in the field makes the next one easier to justify.

The supply chain is still a weakness for the domestic effort

The bullish case for ASML is still strong in the near term. Volumes are tiny, and the domestic supply chain looks incomplete. Key components are reportedly still sourced from Japan, and delays among local suppliers have slowed production this year. That gives ASML time if it can keep serving customers elsewhere while China works through qualification and reliability hurdles.

What this means for ASML's China revenue and the stock

With ASML trading at about 40x forward earnings, the shares still carry premium assumptions. The story here is not an earnings cliff next quarter. It is that ASML's China cash flows should no longer be treated as fully permanent.

The most reasonable stance is selective ownership, not excitement. The near-term earnings impact is still small. The longer-term risk is that investors stop giving ASML full terminal-value weight for its China business if domestic tools keep moving from prototype headlines to usable production assets.